Angelini Ventures
Headquarter
Amsterdam, The Netherlands
Milestones
Founded: 2020
Invested: 2026
CEO
Jim Scibetta, CEO
Linkedin
Vertical
Biotech
Board Participation
Regina Hodits, Board observer
VectorY Therapeutics is a clinical-stage biotechnology company developing vectorized antibody therapies for neurodegenerative diseases, with its lead program VTx-002 in a Phase 1/2 study for amyotrophic lateral sclerosis (ALS).
Related news: